123 related articles for article (PubMed ID: 8225506)
1. Results of an interlaboratory trial of 32P-postlabelling.
Phillips DH; Castegnaro M
IARC Sci Publ; 1993; (124):35-49. PubMed ID: 8225506
[TBL] [Abstract][Full Text] [Related]
2. Differences in detection of DNA adducts in the 32P-postlabelling assay after either 1-butanol extraction or nuclease P1 treatment.
Gallagher JE; Jackson MA; George MH; Lewtas J; Robertson IG
Cancer Lett; 1989 Apr; 45(1):7-12. PubMed ID: 2540901
[TBL] [Abstract][Full Text] [Related]
3. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
[TBL] [Abstract][Full Text] [Related]
4. C18 thin-layer chromatographic enhancement of the 32P-postlabeling assay for aromatic or bulky carcinogen-DNA adducts: evaluation of adduct recoveries in comparison with nuclease P1 and butanol methods.
Reddy MV
J Chromatogr; 1993 May; 614(2):245-51. PubMed ID: 8314936
[TBL] [Abstract][Full Text] [Related]
5. Effect of tissue fixation on recovery of DNA adducts in the 32P-postlabelling assay.
Hewer A; Phillips DH
IARC Sci Publ; 1993; (124):211-4. PubMed ID: 8225487
[TBL] [Abstract][Full Text] [Related]
6. 32P-postlabelling analysis of human tissues and its potential use for biomonitoring.
Jones NJ; McGregor AD; Hoskins PL; Waters R
IARC Sci Publ; 1993; (124):349-55. PubMed ID: 8225505
[TBL] [Abstract][Full Text] [Related]
7. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
Wohlin P; Zeisig M; Gustafsson JA; Möller L
Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
[TBL] [Abstract][Full Text] [Related]
8. Some quantitative considerations about DNA adduct enrichment procedures for 32P-postlabelling.
Vaca CE; Löfgren M; Hemminki K
Carcinogenesis; 1992 Dec; 13(12):2463-6. PubMed ID: 1473258
[TBL] [Abstract][Full Text] [Related]
9. 32P-postlabelling of DNA adducts in styrene oxide-modified DNA and in workers exposed to styrene.
Vodicka P; Hemminki K
IARC Sci Publ; 1993; (127):109-18. PubMed ID: 8070856
[TBL] [Abstract][Full Text] [Related]
10. An improved 32P-postlabelling assay for detection and quantitation of styrene 7,8-oxide-DNA adducts.
Cantoreggi S; Gupta RC; Lutz WK
IARC Sci Publ; 1993; (124):201-5. PubMed ID: 8225485
[TBL] [Abstract][Full Text] [Related]
11. Improvements in the 32P-postlabelling procedure to quantify bulky aromatic DNA adducts.
Steenwinkel MJ; Roggeband R; van Delft JH; Baan RA
IARC Sci Publ; 1993; (124):65-70. PubMed ID: 7693587
[TBL] [Abstract][Full Text] [Related]
12. 32P-postlabelling analysis of small aromatic and of bulky non-aromatic DNA adducts.
Reddy MV
IARC Sci Publ; 1993; (124):25-34. PubMed ID: 8225492
[TBL] [Abstract][Full Text] [Related]
13. Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.
Kovács K; Anna L; Rudnai P; Schoket B
Mutat Res; 2011 Mar; 721(1):95-100. PubMed ID: 21237286
[TBL] [Abstract][Full Text] [Related]
14. 32P-postlabelling methods for cyclic DNA adducts.
Watson WP; Crane AE; Steiner S
IARC Sci Publ; 1993; (124):255-62. PubMed ID: 8225493
[TBL] [Abstract][Full Text] [Related]
15. The use of benzo[a]pyrene diolepoxide-modified DNA standards for adduct quantification in 32P-postlabelling to assess exposure to polycyclic aromatic hydrocarbons: application in a biomonitoring study.
Baan RA; Steenwinkel MJ; van Asten S; Roggeband R; van Delft JH
Mutat Res; 1997 Aug; 378(1-2):41-50. PubMed ID: 9288884
[TBL] [Abstract][Full Text] [Related]
16. Nuclease S1-mediated enhancement of the 32P-postlabeling assay for aromatic carcinogen-DNA adducts.
Reddy MV
Carcinogenesis; 1991 Sep; 12(9):1745-8. PubMed ID: 1893535
[TBL] [Abstract][Full Text] [Related]
17. Cancer biomarkers in human atherosclerotic lesions: detection of DNA adducts.
Izzotti A; De Flora S; Petrilli GL; Gallagher J; Rojas M; Alexandrov K; Bartsch H; Lewtas J
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):105-10. PubMed ID: 7742716
[TBL] [Abstract][Full Text] [Related]
18. 32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies.
Munnia A; Saletta F; Allione A; Piro S; Confortini M; Matullo G; Peluso M
Mutagenesis; 2007 Nov; 22(6):381-5. PubMed ID: 17716983
[TBL] [Abstract][Full Text] [Related]
19. Detection of DNA adducts in human oral tissue: correlation of adduct levels with tobacco smoking and differential enhancement of adducts using the butanol extraction and nuclease P1 versions of 32P postlabeling.
Jones NJ; McGregor AD; Waters R
Cancer Res; 1993 Apr; 53(7):1522-8. PubMed ID: 8453617
[TBL] [Abstract][Full Text] [Related]
20. Absence of DNA adduct formation by phenobarbital, polychlorinated biphenyls, and chlordane in mouse liver using the 32P-postlabeling assay.
Whysner J; Montandon F; McClain RM; Downing J; Verna LK; Steward RE; Williams GM
Toxicol Appl Pharmacol; 1998 Jan; 148(1):14-23. PubMed ID: 9465259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
